| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $336.9M | +80.8% |
| R&D Expense | $140.6M | +37.1% |
| SG&A Expense | $202.2M | +38.6% |
| Operating Income | -$87.6M | +19.7% |
| Pre-tax Income | -$86.9M | +46.5% |
| Income Tax | $1.0M | +3.9% |
| Net Income | -$87.9M | +46.2% |
| EPS (Basic) | -$1.85 | +53.8% |
| EPS (Diluted) | -$1.85 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $222.5M | -22.3% |
| Short-term Investments | $57.8M | — |
| Accounts Receivable | $78.3M | +15.2% |
| Inventory | $22.4M | +0.4% |
| Current Assets | $392.8M | +1.4% |
| Total Assets | $670.8M | +3.7% |
| Current Liabilities | $126.6M | +45.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $10.3M | +114.6% |
| Capital Expenditures | $993K | +811.0% |
| Investing Cash Flow | -$90.1M | +15.9% |
| Financing Cash Flow | $17.7M | -94.7% |
| Free Cash Flow | $9.3M | +113.1% |
| +53.8% |
| Total Liabilities |
| $445.1M |
| +11.9% |
| Stockholders' Equity | $225.6M | -9.3% |